Scynexis (SCYX) Price to Earnings (2014 - 2026)
Scynexis' (SCYX) quarterly Price to Earnings came in at 5.71 in Q2 2026, down 17.15% on a YoY basis from 6.89 in Q2 2025, and down 100.53% quarter-over-quarter from 2.85 in Q1 2026.
Powered by 
Analysis
Scynexis (SCYX) Price to Earnings (2014 - 2026) Analysis & Trends
Scynexis (SCYX) has reported Price to Earnings for 13 consecutive years, with 5.71 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to Earnings fell 17.15% year-over-year to 5.71; the trailing twelve-month figure through Jun 2026 stood at 2.25 (changed 0.08% YoY), and the FY2025 full-year result was 4.05, down 15.13% from the prior year.
- Price to Earnings slipped to 5.71 in Q2 2026 per SCYX's latest filing, from 2.85 in the prior quarter.
- Across five years, Price to Earnings topped out at 373.89 in Q4 2024 and bottomed at 62.15 in Q3 2023.
- Historically, Price to Earnings has averaged 21.09 across 5 years, with a median of 4.55 in 2023.
- The sharpest annual moves came in 2023 and 2024: Price to Earnings sank 1512.66% in 2023, then surged 11849.8% in 2024.
- Over 5 years, Price to Earnings stood at 11.17 in 2022, then surged by 71.5% to 3.18 in 2023, then jumped by 11849.8% to 373.89 in 2024, then sank by 99.48% to 1.96 in 2025, then plunged by 391.73% to 5.71 in 2026.
- According to Business Quant data, Price to Earnings over the past three periods registered 5.71, 2.85, and 1.96 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.71 |
| Mar 31, 2026 | -2.85 |
| Dec 31, 2025 | 1.96 |
| Sep 30, 2025 | -3.76 |
| Jun 30, 2025 | -4.88 |
| Mar 31, 2025 | -8.73 |
| Dec 31, 2024 | 373.89 |
| Sep 30, 2024 | -25.80 |
| Jun 30, 2024 | -6.71 |
| Mar 31, 2024 | 172.56 |
| Dec 31, 2023 | -3.18 |
| Sep 30, 2023 | -62.15 |
| Jun 30, 2023 | 1.15 |
| Mar 31, 2023 | -4.23 |
| Dec 31, 2022 | -11.17 |
| Sep 30, 2022 | -3.85 |
| Jun 30, 2022 | -6.03 |
| Mar 31, 2022 | -20.96 |
| Dec 31, 2021 | -7.12 |
| Sep 30, 2021 | -209.25 |